Epoch Investment Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Epoch Investment Partners's LLY Position: Q2 2026 in Review
Epoch Investment Partners reduced its Eli Lilly (LLY) stake by 2.5% in Q2 2026, selling an estimated $3.19M and leaving 119,698 shares worth $144M. The position accounts for 0.82% of the portfolio, ranked #28.
Epoch Investment Partners first reported a position in LLY in Q1 2020 and has held it in 26 quarters since. The position peaked at $333M in Q4 2023. 4,593 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Epoch Investment Partners held 119,698 shares of Eli Lilly worth $144M as of Q2 2026.
- Epoch Investment Partners sold 3,118 Eli Lilly shares in Q2 2026, an estimated $3.19M.
- Eli Lilly made up 0.82% of Epoch Investment Partners's portfolio in Q2 2026, its #28 holding.
- Epoch Investment Partners first reported a position in Eli Lilly in Q1 2020 and has held it in 26 quarters since.
- Epoch Investment Partners's Eli Lilly position peaked at $333M in Q4 2023.
- 4,593 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Epoch Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.